Patient info Open main menu

J05AP Antivirals for treatment of HCV infections

ATC group of level 4 – chemical subgroup · in plain English: medicines against viruses, e.g. HIV or hepatitis

This site has the patient leaflet or the SPC of 25 medicines in this group and its subgroups.

Place in the ATC classification

  1. J Antiinfectives for systemic use 1,393 medicines
    1. J05 Antivirals for systemic use 392 medicines
      1. J05A Direct acting antivirals 392 medicines
        1. J05AP Antivirals for treatment of HCV infections 25 medicines
          1. J05AP01 ribavirin 6 medicines
          2. J05AP07 daclatasvir 1 medicine
          3. J05AP08 sofosbuvir 4 medicines
          4. J05AP09 dasabuvir 1 medicine
          5. J05AP51 sofosbuvir and ledipasvir 4 medicines
          6. J05AP53 ombitasvir, paritaprevir and ritonavir 1 medicine
          7. J05AP54 elbasvir and grazoprevir 2 medicines
          8. J05AP55 sofosbuvir and velpatasvir 4 medicines
          9. J05AP57 glecaprevir and pibrentasvir 2 medicines

10 more subgroups have no medicine with a leaflet on this site.

Active substances in the group

Medicines in the group and its subgroups

MedicineLegal category
Daklinza SPC no longer supplied (J05AP07 daclatasvir) –
Epclusa 150 mg/37.5 mg coated granules in sachet SPC (J05AP55 sofosbuvir and velpatasvir) Prescription only (POM)
Epclusa 200 mg / 50 mg film-coated tablets SPC (J05AP55 sofosbuvir and velpatasvir) Prescription only (POM)
Epclusa 200 mg/50 mg coated granules in sachet SPC (J05AP55 sofosbuvir and velpatasvir) Prescription only (POM)
Epclusa 400 mg / 100 mg film-coated tablets SPC (J05AP55 sofosbuvir and velpatasvir) Prescription only (POM)
Exviera SPC no longer supplied (J05AP09 dasabuvir) –
Glecaprevir/pibrentasvir 100 mg/40 mg film-coated tablets (J05AP57 glecaprevir and pibrentasvir) Prescription only (POM)
Harvoni 33.75 mg / 150 mg coated granules in sachet no longer supplied (J05AP51 sofosbuvir and ledipasvir) –
Harvoni 45 mg / 200 mg coated granules in sachet SPC no longer supplied (J05AP51 sofosbuvir and ledipasvir) –
Harvoni 90 mg / 400 mg film-coated tablets SPC (J05AP51 sofosbuvir and ledipasvir) Prescription only (POM)
Ledipasvir/sofosbuvir Gilead 45 mg/200 mg film-coated tablets no longer supplied (J05AP51 sofosbuvir and ledipasvir) –
Maviret 50 mg / 20 mg coated granules in sachet SPC (J05AP57 glecaprevir and pibrentasvir) Prescription only (POM)
Rebetol SPC no longer supplied (J05AP01 ribavirin) –
Ribavirin 200 mg capsules hard SPC (J05AP01 ribavirin) Prescription only (POM)
Ribavirin 200 mg film-coated tablets SPC (J05AP01 ribavirin) Prescription only (POM)
Ribavirin 400 mg film-coated tablets SPC not available (J05AP01 ribavirin) –
Ribavirin Teva Pharma B.V. SPC (J05AP01 ribavirin) –
Ribavirin Teva Pharma B.V. 200 mg film-coated tablets SPC (J05AP01 ribavirin) Prescription only (POM)
Sovaldi 150 mg coated granules SPC no longer supplied (J05AP08 sofosbuvir) –
Sovaldi 200 mg coated granules no longer supplied (J05AP08 sofosbuvir) –
Sovaldi 200 mg film-coated tablets SPC no longer supplied (J05AP08 sofosbuvir) –
Sovaldi 400 mg film-coated tablets SPC (J05AP08 sofosbuvir) Prescription only (POM)
Viekirax SPC no longer supplied (J05AP53 ombitasvir, paritaprevir and ritonavir) –
Zepatier SPC no longer supplied (J05AP54 elbasvir and grazoprevir) –
Zepatier 50 mg / 100 mg film-coated tablets SPC no longer supplied (J05AP54 elbasvir and grazoprevir) –

Other groups of the same level

Other names of the ATC group

Sources

  • Patient leaflets and SPCs: the MHRA product information (products.mhra.gov.uk) and the European Medicines Agency (EMA)
  • Active substances, ATC codes and legal categories: the NHS Dictionary of Medicines and Devices (dm+d), NHS Business Services Authority
  • World Health Organization (WHO): ATC/DDD classification, group J05AP

Contains public sector information licensed under the Open Government Licence v3.0.

Ask your doctor or pharmacist which medicine is right for you.